Mitogenic activity but not phenotype expression of rat osteoprogenitor cells in response to IGF-I is impaired in aged rats

Mechanisms of Ageing and Development

Volumn 92, Issue 1, 1996, Pages 1-10

  Tanaka, Hiroshi ^a   Liang, C Tony ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; DNA synthesis; Gene expression; IGF I; IGF I receptor; Osteoprogenitor cells

Indexed keywords

MESSENGER RNA; SOMATOMEDIN C;

AGED; AGING; ANIMAL CELL; ARTICLE; MALE; MITOGENESIS; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; RAT; SCATCHARD PLOT; SIGNAL TRANSDUCTION; STEM CELL;

AGING; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR I; MALE; PHENOTYPE; RATS; RATS, WISTAR; STROMAL CELLS;

EID: 0030606145     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(96)01793-9     Document Type: Article

References (26)

1. [1] E.R. Froesch, J. Zapf, T.K. Audhya, E. Ben-Porath, B.J. Segen and K.D. Gibson, Nonsuppressible insulin-like activity and thyroid hormone: major pituitary-dependent sulfation factors for chick embryo cartilage. Proc. Natl. Acad. Sci. USA, 73 (1976) 2904-2908.
2. [2] E. Canalis, Effect of insulin-like growth factor I on DNA and protein synthesis in cultured calvaria. J. Clin. Invest., 66 (1980) 709-719.
3. [3] N.L. Schlechter, S.M. Russell, E.M. Spencer and C.S. Nicoll, Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc. Natl. Acad. Sci. USA, 83 (1986) 932-7934.
4. [4] G.A. Rodan, Introduction to bone biology. Bone, 13 (1992) 53-56.
5. [5] E. Canalis, T.L. McCarthy, and M. Centrella, Growth factors and cytokines in bone cell metabolism. Ann. Rev. Med., 42 (1991) 17-24.
6. [6] T.L. McCarthy, M. Centrella and E. Canalis, Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology, 124 (1989) 301-309.
7. [7] C. Schmid, H.-P. Guler, D. Rowe and E.R. Froesh, Insulin-like growth factor-I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats. Endocrinology, 125 (1989) 1575-1580.
8. [8] J.M. Hock, M. Centrella and E. Canalis, Insulin-like growth factor-I has independent effects on bone matrix formation and cell replication. Endocrinology, 122 (1988) 254-260.
9. [9] S.P. Nissley and W. Lopaczynski, Insulin-like growth factor receptor. Growth Factors, 5 (1991) 29-43.
10. [10] M.E. Owen, J. Cave and C.J. Joyner, Clonal analysis in vitro of osteogenic differentiation of marrow stromal CFU-F. J. Cell Sci., 87 (1987) 731-738.
11. [11] R. Quarto, D. Thomas and C.T. Liang, Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif. Tissue Int., 56 (1995) 123-129.
12. [12] T. Tsuji, F.J. Hughes, C.A.G. McCulloch and A.H. Melcher, Effect of donor age on osteogenic cells of rat bone marrow in vitro. Mech. Aging Dev., 51 (1990) 1129-1136.
13. [13] D. Egrise, D. Martin, P. Neve, M. Verhas and A. Schoutens, The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats. Bone, 13 (1992) 355-361.
14. [14] H. Tanaka, J. Barnes and C.T. Liang, Effect of age on the expression of insulin-like growth factor-I, interleukin-6 and transforming growth factor-β mRNAs in rat femurs following marrow ablation. Bone, 18 (1996) 473-478.
15. [15] H. Tanaka, R. Quarto, S. Williams, J. Barnes and C.T. Liang, In vivo and in vitro effects of insulin-like growth factor-I (IGF-I) on femoral mRNA expression in old rats. Bone, 15 (1994) 647-635.
16. [16] H. Erlich (ed.), In PCR Technology: Principle and Applications for DNA Amplification, Stockton Press, New York, 1989, pp. 89-97.
17. [17] H. Werner, M. Woloschak, M. Adama, Z. Shen-Orr, C.T. Roberts, Jr. and D. LeRoith, Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA, 86 (1989) 7451-7455.
18. [18] U. Nudel, R. Zakut, M. Shani, S. Neuman, Z. Levy and D. Yaffe, The nucleotide sequence of the rat cytoplasmic β-actin. Nucleic Acids Res., 11 (1983) 1759-1771.
19. [19] C.T. Liang, J. Barnes, J.G. Seedor et al., Impaired bone activity in aged rats: alteration at the cellular and molecular levels. Bone, 13 (1992) 431-435.
20. [20] M.C. Hollander and A.J. Forance, Jr., Estimation of relative mRNA content by filter hybridization to a polythymidylate probe. Biotechniques, 9 (1990) 174-179.
21. [21] W. Kiess, J.F. Haskell, L. Lee et al., An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biological responses in L6 myoblasts. J. Biol. Chem., 262 (1987) 12745-12750.
22. [22] C. Sell, A. Ptasznik, C.D. Chang, J. Swantek, V.J. Cristofalo and R. Basserga, IGF-1 receptor levels and the proliferation of young and senescent human fibroblasts. Biochem. Biophys. Res. Commun., 194 (1993) 259-265.
23. [23] K. Raile, A. Hoflich, U. Kessler et al., Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. J. Cell. Physiol., 159 (1994) 531-541.
24. [24] H. Mochizuki, Y. Hakeda, N. Wakatuki et al., Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology, 131 (1992) 1075-1080.
25. [25] R.G. Rosenfeld and R.L. Hintz, Characterization of specific receptor for somatomedin C (SM-C) on cultured human lymphocytes: evidence that SM-C modulates homologous receptor concentration. Endocrinology, 107 (1980) 1841-1848.
26. 2 in normal and postmenopausal osteoporotic women. J. Bone Miner. Res., 5 (1990) 1149-1155.